Clinical Trials on Ventricular Hypertrophy in France

Total 310 results

University Hospital, Caen

Completed

Longitudinal Analysis of Right Ventricular Remodeling in Response to Prolonged Strength Training Using 3D-echocardiography (FORCE-VD)

Right Ventricular Hypertrophy | Cardiac Remodeling, Ventricular

France
Assistance Publique - Hôpitaux de Paris
Institute of Cardiometabolism and Nutrition, France

Not yet recruiting

Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging (PROMOMA)

Left Ventricular Hypertrophy

France
Hospices Civils de Lyon

Recruiting

Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data. (ORCHID)

Cardiomyopathies | Left Ventricular Hypertrophy | Hypertension Arterial | Hypokinetic

France
University Hospital, Strasbourg, France

Unknown

Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis

Aortic Valve Stenosis | Ventricular Hypertrophy

France
Jean-Luc Balligand
University of Oxford; University of Athens; Cliniques universitaires Saint-Luc-... and other collaborators

Active, not recruiting

Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure (Beta3_LVH)

Hypertrophy, Left Ventricular

Belgium, France, Germany, Greece, Italy, Poland, Portugal, United Kingdom
Centre Hospitalier Universitaire, Amiens

Recruiting

Gastric Tube in Pyloric Stenosis (SONPYL)

Respiratory Complication | Hypertrophic Pyloric Stenosis

France
French Cardiology Society

Recruiting

French Hypertrophic Cardiomyopathy Observatory (REMY)

Hypertrophic Cardiomyopathy

France
University Hospital, Limoges

Withdrawn

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study (ARISTOTE)

Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Hypertrophy, Left Ventricular | Angiotensin Receptor Antagonists | Heart Valve Prosthesis Implantation | Valsartan

France
French Cardiology Society

Completed

Neurohormonal Parameters in Hypertrophic Cardiomyopathies (REEF-CMH)

1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy | 2- Obstructive Hypertrophic Cardiomyopathy | 3- Non Obstructive Hypertrophic Cardiomyopathy

France
University Hospital, Montpellier

Unknown

Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography (CMHStress)

Hypertrophic Cardiomyopathy

France
Assistance Publique Hopitaux De Marseille

Unknown

New Diagnostic Strategy in Hypertrophic Cardiomyopathy (HYPERGEN)

Hypertrophic Cardiomyopathy

France
Centre Hospitalier Universitaire, Amiens

Completed

4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy (CMHFLUX)

Hypertrophic Cardiomyopathy | Obstruction | Echocardiography

France
Pr. Nicolas GIRERD

Recruiting

Machine Learning Approach Based on Echocardiographic Data to Improve Prediction of Cardiovascular Events in Hypertrophic Cardiomyopathy (2022PI172)

Hypertrophic Cardiomyopathy

France
Nantes University Hospital
Institut National de la Santé Et de la Recherche Médicale, France; Rennes University... and other collaborators

Recruiting

Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy (HCM)

Hypertrophic Cardiomyopathy

France
University Hospital, Bordeaux

Completed

Hypertrophic Cardiomyopathy Symptom Release by BX1514M (Light-CARMIDO)

Hypertrophic Cardiomyopathy

France
Assistance Publique - Hôpitaux de Paris

Unknown

Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy (OPTIM-HCM)

Hypertrophic Cardiomyopathy

France
University Hospital, Bordeaux
Amicus Therapeutics; Fédération Française de Cardiologie; Fondation Bordeaux...

Completed

Assessment of the Relations Between Endothelial and Venous Dysfunctions and Left Ventricular Obstruction in Genetic Hypertrophic Cardiomyopathies (HCM-Vein)

Endothelial Dysfunction | Hypertrophic Cardiomyopathy

France
University Hospital, Bordeaux

Completed

Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response (HSYNC)

Hypertrophic Cardiomyopathy | Mechanical Hyper-synchronicity

France
Hospices Civils de Lyon

Completed

3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (3D-CMH)

Hypertrophic Cardiomyopathy

France
Thibaud Damy

Completed

Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy (Amylo)

Cardiac Amyloidosis | Hypertrophic Cardiomyopathy (HCM) | Amyloidosis in Transthyretin (TTR)

France
Bristol-Myers Squibb

Active, not recruiting

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

Hypertrophic Cardiomyopathy | Non-obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic Cardiomyopathy

Denmark, United States, Belgium, Czechia, France, Germany, Israel, Italy, Netherlands, Poland, Portugal, Spain, United Kingdom
University Hospital, Montpellier
Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute

Completed

Physical Activity in Children With Inherited Cardiac Diseases

Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Brugada Syndrome | Long QT Syndrome | Catecholaminergic Polymorphic Ventricular Tachycardia

France
University Hospital, Montpellier
Hospices Civils de Lyon; University Hospital, Bordeaux; University Hospital,... and other collaborators

Completed

Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations (QUALIMYORYTHM)

Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Brugada Syndrome | Long QT Syndrome | Arrhythmogenic Right Ventricular Dysplasia | Catecholaminergic Polymorphic Ventricular Tachycardia | Restrictive Cardiomyopathy

France
Cytokinetics

Recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM (MAPLE-HCM)

Obstructive Hypertrophic Cardiomyopathy (oHCM)

United States, Denmark, Spain, Netherlands, United Kingdom, Germany, France, China, Israel, Italy, Hungary, Canada
Cytokinetics

Enrolling by invitation

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM (FOREST-HCM)

Symptomatic Hypertrophic Cardiomyopathy (HCM)

United States, France, Israel, Spain, United Kingdom, Italy, Portugal, Poland, Hungary, Denmark, Netherlands, Germany, Czechia
Cytokinetics
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.

Completed

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM (SEQUOIA-HCM) (SEQUOIA-HCM)

Obstructive Hypertrophic Cardiomyopathy (oHCM)

United States, France, Spain, Portugal, Germany, China, United Kingdom, Israel, Netherlands, Denmark, Czechia, Hungary, Italy, Poland
MyoKardia, Inc.

Completed

Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM)

Obstructive Hypertrophic Cardiomyopathy

United States, France, Germany, Czechia, Spain, Belgium, Denmark, Portugal, Netherlands, Israel, Poland, United Kingdom, Italy
Ramsay Générale de Santé
Hôpital Privé d'Antony - Dr Dunet

Unknown

Reduction of Breast Enlargement Using the Da Vinci Xi Robot (R-HTM-R)

Breast Hypertrophy

France
Groupe Hospitalier Nord-Essonne

Recruiting

Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery (R-HTM-R)

Breast Reduction

France
Pfizer

Completed

Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology (TTRACK)

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Italy, Romania, France, Australia, Austria, Portugal, Slovakia, Slovenia, Spain, United Kingdom
Bristol-Myers Squibb

Active, not recruiting

A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy (ODYSSEY-HCM)

Cardiomyopathy, Hypertrophic

Spain, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Hungary, Israel, Japan, Netherlands, Norway, Poland, Portugal, United Kingdom, United States, Australia, China, Czechia, India, Italy, Korea, Republic of
University Hospital, Tours

Completed

Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound (PROPIL)

Prostatic Hypertrophy, Benign

France
Bristol-Myers Squibb

Recruiting

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cardiomyopathy, Hypertrophic

United States, Australia, Canada, France, Germany, Ireland, Italy, Spain, United Kingdom
Gilead Sciences

Terminated

Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM)

Hypertrophic Cardiomyopathy

Australia, United States, Netherlands, Israel, Italy, France, Germany, United Kingdom
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Ultrasound and Left Ventricular Systolic Function (EFESE)

Dysfunction, Left Ventricular

France
Bristol-Myers Squibb

Recruiting

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy (MEMENTO)

Cardiomyopathy, Hypertrophic

United States, Argentina, Australia, Belgium, Canada, Czechia, Hungary, Poland, Switzerland, France, Austria, Finland, Germany, Greece, Italy, Spain, United Kingdom
University Hospital, Montpellier

Completed

Cardiovascular Consequences in Intense and Extended Physical Exercise (PHILIPPIDES)

Right Ventricular Dysfunction | Ventricular Arrythmia

France
University Hospital, Montpellier

Terminated

Right Ventricular Dysfunction Incidence After Major Lung Resection (RESECHO)

Right Ventricular Dysfunction | Major Lung Resection

France
Assistance Publique Hopitaux De Marseille

Completed

Prognosis of Isolated Left Ventricular Non-compaction in Adults (NCVG)

Left Ventricular Non Compaction

France
Centre Hospitalier Universitaire, Amiens

Recruiting

Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery (SPECKLETHO)

Thoracic Surgery | Right Ventricle

France
University Hospital, Clermont-Ferrand

Completed

Use of Pre-operative Global Longitudinal Strain to Predict Post-operative Left Ventricular Dysfunction in Mitral Regurgitation Surgery (DysPO IM)

Severe Mitral Regurgitation | Preserved Ventricular Ejection Fraction

France
University Hospital, Montpellier

Completed

Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care

Ventricular Failure

France
ClinSearch
Biocompatibles UK Ltd; European Georges Pompidou Hospital

Unknown

Prostate Embolization for Acute Urinary Retention Study (PARIS1)

Prostatic Hypertrophy, Benign

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB) (PROVERB)

Heart Failure | Revascularization

France
University Hospital, Caen

Completed

Intracardiac Flow Remodeling in Athletes (INFINITE)

Cardiac Remodeling, Ventricular

France
Assistance Publique Hopitaux De Marseille

Completed

Prostate Cancer Antigen 3 (PCA-3) Gene Project

Prostate Cancer | Benign Prostatic Hypertrophy

France
University Hospital, Montpellier

Completed

Segment IV Hypertrophy After Liver Venous Deprivation

Major Hepatectomy

France
University Hospital, Clermont-Ferrand
Centre Jean Perrin

Unknown

Rest/Stress Quantification Of Left Ventricular Dyssynchrony By 3D Gated Blood Pool D-SPECT

Left Ventricular Dyssynchrony

France
Centre Hospitalier Universitaire de Nice

Completed

Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours (PRECOCE)

Benign Prostatic Hypertrophy

France

Clinical Trials on Ventricular Hypertrophy in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations